{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:38:44Z","timestamp":1787647124970,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","funder":[{"name":"University of Michigan Medical School AP Research Project Funding Committee","award":["U084984"],"award-info":[{"award-number":["U084984"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>The morphologic features of uterine smooth muscle tumors (USMTs) are subject to interobserver variability and are complicated by consideration of features of fumarate hydratase deficiency (FHd) and other morphologic subtypes, with difficult cases occasionally diagnosed as smooth muscle tumor of uncertain malignant potential (STUMP). We compare immunohistochemical findings and detailed morphologic analysis of 45 USMTs by 4 fellowship-trained gynecologic pathologists with comprehensive molecular analysis, focusing on FHd leiomyomas (n=15), compared to a variety of other USMTs with overlapping morphologic features, including 9 STUMPs, 8 usual-type leiomyomas (ULM), 11 apoplectic leiomyomas, and 2 leiomyomas with bizarre nuclei (LMBN). FHd leiomyomas, defined by immunohistochemical (IHC) loss of FH and\/or 2SC accumulation, showed <jats:italic toggle=\"yes\">FH<\/jats:italic> mutations and\/or <jats:italic toggle=\"yes\">FH<\/jats:italic> copy loss in all cases, with concurrent <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutations in 2 tumors. Severe and\/or symplastic-type cytologic atypia was seen more often in FHd leiomyomas with only <jats:italic toggle=\"yes\">FH<\/jats:italic> copy loss (6\/8, and 2\/2 with concurrent <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutations) compared to those with <jats:italic toggle=\"yes\">FH<\/jats:italic> mutations (2\/7) and typically showed increased genomic instability. This subset of FHd tumors often showed morphologic overlap with STUMPs and LMBN, but all cases of FHd tumors showed 2SC accumulation and\/or FH loss by IHC. In conclusion, we highlight the importance of investigating USMTs with severe and\/or symplastic-type cytologic atypia with FH and 2SC IHC, as many of these tumors are FH-deficient via focal deep deletion (2-copy loss) of the <jats:italic toggle=\"yes\">FH<\/jats:italic> locus. In addition, we report the presence of concurrent <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutations in FHd tumors with more severe cytologic atypia; further data about clinical outcomes for these tumors are needed.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001101","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:00:49Z","timestamp":1737993649000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The Morphologic and Molecular Heterogeneity of Fumarate Hydratase\u2013deficient Leiomyomas: Integrative Molecular Profiling of Uterine Smooth Muscle Tumors With Histologic Feature Correlation"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-9857","authenticated-orcid":false,"given":"Julianne M.","family":"Szczepanski","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Chapel","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh","family":"Pham","sequence":"additional","affiliation":[{"name":"Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mannan","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Michigan Center for Translational Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Michigan Center for Translational Pathology"},{"name":"Rogel Cancer Center, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Sciallis","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Tomlins","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Skala","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Rogel Cancer Center, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Udager","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Michigan Center for Translational Pathology"},{"name":"Rogel Cancer Center, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"R1-20250127","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R2-20250127","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/PAS.0b013e3182851162","article-title":"Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma","volume":"37","author":"Lim","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R3-20250127","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R4-20250127","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","article-title":"Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases","volume":"40","author":"Miettinen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R5-20250127","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PGP.0000000000000797","article-title":"Fumarate hydratase deficiency should be considered in the differential diagnosis of uterine and extrauterine smooth muscle tumors of uncertain malignant potential (STUMP)","volume":"41","author":"Pors","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R6-20250127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PGP.0000000000000918","article-title":"Fumarate hydratase and S-(2-Succinyl)-cysteine immunohistochemistry shows evidence of fumarate hydratase deficiency in 2% of uterine leiomyosarcomas: a cohort study of 348 tumors","volume":"42","author":"Chapel","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20250127","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/PAS.0b013e3181a02d1c","article-title":"Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases","volume":"33","author":"Ip","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R9-20250127","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2559.2005.02292.x","article-title":"Evaluation of biological potential of smooth muscle tumours","volume":"48","author":"Miettinen","year":"2006","journal-title":"Histopathology"},{"key":"R10-20250127","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.13515","article-title":"Predictors of adverse outcome in uterine smooth muscle tumours of uncertain malignant potential (STUMP): a clinicopathological analysis of 22 cases with a proposal for the inclusion of additional histological parameters","volume":"73","author":"Gupta","year":"2018","journal-title":"Histopathology"},{"key":"R11-20250127","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PGP.0b013e31815ea7f5","article-title":"Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors","volume":"27","author":"Chen","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20250127","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/modpathol.2009.122","article-title":"A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors","volume":"22","author":"Lee","year":"2009","journal-title":"Mod Pathol"},{"key":"R13-20250127","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-20250127","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"M\u00e4kinen","year":"2011","journal-title":"Science"},{"key":"R15-20250127","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41379-020-0596-y","article-title":"Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants","volume":"33","author":"Popp","year":"2020","journal-title":"Mod Pathol"},{"key":"R16-20250127","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","author":"Abeshouse","year":"2017","journal-title":"Cell"},{"key":"R17-20250127","doi-asserted-by":"crossref","first-page":"e1005850","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12","volume":"12","author":"M\u00e4kinen","year":"2016","journal-title":"PLoS Genet"},{"key":"R18-20250127","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat Commun"},{"key":"R19-20250127","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/cas.13613","article-title":"Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma","volume":"109","author":"Tsuyoshi","year":"2018","journal-title":"Cancer Sci"},{"key":"R20-20250127","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/bjc.2012.428","article-title":"Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer","volume":"107","author":"K\u00e4mpj\u00e4rvi","year":"2012","journal-title":"Br J Cancer"},{"key":"R21-20250127","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/PAS.0000000000000249","article-title":"Uterine leiomyomas with bizarre nuclei: a clinicopathologic study of 59 cases","volume":"38","author":"Croce","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R22-20250127","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/PGP.0000000000000837","article-title":"Uterine leiomyosarcoma associated with leiomyoma with bizarre nuclei: histology and genomic analysis of two cases","volume":"41","author":"Fischer","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R23-20250127","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2147\/IJWH.S388278","article-title":"Leiomyoma with bizarre nuclei: a current update","volume":"14","author":"Guo","year":"2022","journal-title":"Int J Womens Health"},{"key":"R24-20250127","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/modpathol.2016.107","article-title":"Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors","volume":"29","author":"Liegl-Atzwanger","year":"2016","journal-title":"Mod Pathol"},{"key":"R25-20250127","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/modpathol.2009.96","article-title":"Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas","volume":"22","author":"Mittal","year":"2009","journal-title":"Mod Pathol"},{"key":"R26-20250127","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/modpathol.2015.3","article-title":"Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions","volume":"28","author":"Croce","year":"2015","journal-title":"Mod Pathol"},{"key":"R27-20250127","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/modpathol.2017.185","article-title":"Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors","volume":"31","author":"Croce","year":"2018","journal-title":"Mod Pathol"},{"key":"R28-20250127","doi-asserted-by":"crossref","first-page":"e23229","DOI":"10.1002\/gcc.23229","article-title":"Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: strengths, weaknesses, and limitations of array-CGH interpretation","volume":"63","author":"Fontanges","year":"2024","journal-title":"Genes Chromosomes Cancer"},{"key":"R29-20250127","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41379-020-0548-6","article-title":"Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation","volume":"33","author":"Skala","year":"2020","journal-title":"Mod Pathol"},{"key":"R30-20250127","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1158\/1078-0432.CCR-19-1669","article-title":"CDKN1B deletions are associated with metastasis in African American men with clinically localized, surgically treated prostate cancer","volume":"26","author":"Faisal","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R31-20250127","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.humpath.2014.06.003","article-title":"HRAS mutations are frequent in inverted urothelial neoplasms","volume":"45","author":"McDaniel","year":"2014","journal-title":"Hum Pathol"},{"key":"R32-20250127","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jmoldx.2014.09.008","article-title":"Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data","volume":"17","author":"Grasso","year":"2015","journal-title":"J Mol Diagn"},{"key":"R33-20250127","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","article-title":"Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients","volume":"39","author":"Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R34-20250127","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/PAS.0000000000000646","article-title":"Two subtypes of atypical leiomyoma: clinical, histologic, and molecular analysis","volume":"40","author":"Ubago","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R35-20250127","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PGP.0000000000000447","article-title":"Fumarate hydratase mutations and alterations in leiomyoma with bizarre nuclei","volume":"37","author":"Zhang","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R36-20250127","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/modpathol.2017.56","article-title":"Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"R37-20250127","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bpobgyn.2011.07.003","article-title":"Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential","volume":"25","author":"Ip","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:01:03Z","timestamp":1737993663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001101","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}